Intramuscular Administration of Drotaverine Hydrochloride Decreases Both Incidence of Urinary Retention and Time to Micturition in Orthopedic Patients under Spinal Anesthesia: A Single Blinded Randomized Study

Dariusz Tomaszewski, Mariusz Bałkota, Dariusz Tomaszewski, Mariusz Bałkota

Abstract

Purpose: Postoperative urinary retention (POUR) increases the duration of hospitalization and frequency and risk of urinary bladder catheterization. The objective of this study was to analyze the efficacy of intramuscularly administered drotaverine hydrochloride in the prevention of POUR in orthopedic patients.

Methods: Two hundred and thirty patients 17-40 years of age undergoing lower limb orthopedic procedures under spinal anesthesia were enrolled in the study. The study group received 40 mg of drotaverine hydrochloride intramuscularly; the second group was the control. The main outcome measure was (1) the time to micturition and (2) the incidence of urinary bladder catheterization and time to catheterization.

Results: Two hundred and one patients of 230 enrolled participants completed the study. Compared to the control group, the male patients in study group exhibited a shorter time to spontaneous micturition (441 versus 563 minutes, 95% CI of the difference of means between 39 and 205 minutes) and a lower incidence of urinary bladder catheterization (4/75 versus 10/54) (RR 0.29, 95% CI: 0.1-0.87; P = 0.0175).

Conclusions: Intramuscular administration of drotaverine hydrochloride decreased the time to spontaneous micturition and decreased the incidence of urinary bladder catheterization in male patients who underwent orthopedic surgery under spinal anesthesia. This trial is registered with NCT02026427.

Figures

Figure 1
Figure 1
Flow of the participants in the study.
Figure 2
Figure 2
The comparison of the time (in minutes) from the onset of spinal anesthesia to spontaneous micturition in study population. White boxplot: both men and women; light grey: women; dark grey: men.

References

    1. Baldini G., Bagry H., Aprikian A., Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology. 2009;110(5):1139–1157. doi: 10.1097/aln.0b013e31819f7aea.
    1. Choi S., Mahon P., Awad I. T. Neuraxial anesthesia and bladder dysfunction in the perioperative period: a systematic review. Canadian Journal of Anesthesia. 2012;59(7):681–703. doi: 10.1007/s12630-012-9717-5.
    1. Hansen B. S., Søreide E., Warland A. M., Nilsen O. B. Risk factors of post-operative urinary retention in hospitalised patients. Acta Anaesthesiologica Scandinavica. 2011;55(5):545–548. doi: 10.1111/j.1399-6576.2011.02416.x.
    1. Keita H., Diouf E., Tubach F., et al. Predictive factors of early postoperative urinary retention in the postanesthesia care unit. Anesthesia and Analgesia. 2005;101(2):592–596. doi: 10.1213/01.ane.0000159165.90094.40.
    1. Feliciano T., Montero J., McCarthy M., Priester M. A retrospective, descriptive, exploratory study evaluating incidence of postoperative urinary retention after spinal anesthesia and its effect on PACU discharge. Journal of Perianesthesia Nursing. 2008;23(6):394–400. doi: 10.1016/j.jopan.2008.09.006.
    1. Dellimore K. H., Helyer A. R., Franklin S. E. A scoping review of important urinary catheter induced complications. Journal of Materials Science: Materials in Medicine. 2013;24(8):1825–1835. doi: 10.1007/s10856-013-4953-y.
    1. Bałkota M., Tomaszewski D., Truszczyński A., Sokół-Kobielska E. Skuteczność domięśniowo podawanej neostygminy w zapobieganiu zatrzymania moczu u chorych znieczulanych podpajęczynówkowo. [The efficacy of the intramuscularly administered neostigmine in the prevention of urinary retention after spinal anesthesia] Lekarz Wojskowy. 2013;91(4):410–415.
    1. Kreutziger J., Frankenberger B., Luger T. J., Richard S., Zbinden S. Urinary retention after spinal anaesthesia with hyperbaric prilocaine 2% in an ambulatory setting. British Journal of Anaesthesia. 2010;104(5):582–586. doi: 10.1093/bja/aeq054.
    1. Ehrenberg R., Lemberger P., Wiesenack C. Urinary retention after spinal anaesthesia: unilateral vs. bilateral spinal anaesthesia with 0.5% bupivacain. a prospective randomized study: 8AP6-2. European Journal of Anaesthesiology. 2008;25:p. 119. doi: 10.1097/00003643-200805001-00379.
    1. Sung K. H., Lee K. M., Chung C. Y., et al. What are the risk factors associated with urinary retention after orthopaedic surgery? BioMed Research International. 2015;2015:5. doi: 10.1155/2015/613216.613216
    1. Pavlin D. J., Pavlin E. G., Gunn H. C., Taraday J. K., Koerschgen M. E. Voiding in patients managed with or without ultrasound monitoring of bladder volume after outpatient surgery. Anesthesia & Analgesia. 1999;89(1):90–97. doi: 10.1097/00000539-199907000-00016.
    1. Alsaidi M., Guanio J., Basheer A., et al. The incidence and risk factors for postoperative urinary retention in neurosurgical patients. Surgical Neurology International. 2013;4(article 61) doi: 10.4103/2152-7806.111088.
    1. NO-SPA. Summary of product characteristics. June 2015, .
    1. Bolaji O. O., Onyeji C. O., Ogundaini A. O., Olugbade T. A., Ogunbona F. A. Pharmacokinetics and bioavailability of drotaverine in humans. European Journal of Drug Metabolism and Pharmacokinetics. 1996;21(3):217–221. doi: 10.1007/BF03189716.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir